Login / Signup

A phase 2 clinical trial of nivolumab and temozolomide for neuroendocrine neoplasms.

Dwight H OwenBrooke BennerLai WeiVineeth K SukrithanAshima GoyalYe ZhouCarly PilcherSheryl-Ann SuffrenGwen ChristensonNancy CurtisMegan JukichEmily SchwarzHimanshu SavardekarRuthann NormanSarah FergusonBarbara KleiberRobert WesolowskiWilliam E CarsonGregory A OttersonClaire F VerschraegenManisha H ShahBhavana Konda
Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Combination nivolumab and temozolomide demonstrated promising activity in NEN.
Keyphrases
  • clinical trial
  • newly diagnosed
  • phase ii
  • open label
  • study protocol